Toll-like receptor 4 polymorphism associated with the response to whole-cell pertussis vaccination in children from the KOALA study

Clinical and Vaccine Immunology

Volumn 14, Issue 10, 2007, Pages 1377-1380

  Banus, Sander ^a   Bottema, Renske W B ^b   Siezen, Christine L E ^a   Vandebriel, Rob J ^a   Reimerink, Johan ^a   Mommers, Monique ^c,d   Koppelman, Gerard H ^e   Hoebee, Barbara ^a   Thijs, Carel ^c,d   Postma, Dirkje S ^b   Kimman, Tjeerd G ^a   Stelma, Foekje F ^f  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS TOXIN; PERTUSSIS VACCINE; TOLL LIKE RECEPTOR 4;

ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; GENE FREQUENCY; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INFANT; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; VACCINATION; WHOLE CELL;

ANIMALS; COHORT STUDIES; HUMANS; IMMUNITY, ACTIVE; INFANT; MICE; MICE, INBRED C3H; PERTUSSIS VACCINE; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 4; VACCINES, ATTENUATED;

EID: 35548944489     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.00175-07     Document Type: Article

References (32)

1. Agnese, D. M., J. E. Calvano, S. J. Hahm, S. M. Coyle, S. A. Corbett, S. E. Calvano, and S. F. Lowry. 2002. Human Toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections. J. Infect. Dis. 186:1522-1525.
2. Arbour, N. C., E. Lorenz, B. C. Schutte, J. Zabner, J. N. Kline, M. Jones, K. Frees, J. L. Watt, and D. A. Schwartz. 2000. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat. Genet. 25:187-191.
3. Ausiello, C. M., R. Lande, F. Urbani, A. La Sala, P. Stefanelli, S. Salmaso, P. Mastrantonio, and A. Cassone. 1999. Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines. Infect. Immun. 67:4064-4071.
4. Banus, H. A., H. J. van Kranen, F. R. Mooi, B. Hoebee, N. J. Nagelkerke, P. Demant, and T. G. Kimman. 2005. Genetic control of Bordetella pertussis infection: identification of susceptibility loci using recombinant congenic strains of mice. Infect. Immun. 73:741-747.
5. Banus, H. A., R. J. Vandebriel, H. de Ruiter, J. A. Dormans, N. J. Nagelkerke, F. R. Mooi, B. Hoebee, H. J. van Kranen, and T. G. Kimman. 2006. Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology. Infect. Immun. 74:2596-2605.
6. Barrett, J. C., B. Fry, J. Maller, and M. J. Daly. 2005. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
7. Bastiaanssen, J. M., R. A. de Bie, C. H. Bastiaenen, A. Heuts, M. E. Kroese, G. G. Essed, and P. A. van den Brandt. 2005. Etiology and prognosis of pregnancy-related pelvic girdle pain: design of a longitudinal study. BMC Public Health 5:1.
8. Brass, J. B., and G. R. Siber. 2002. Quantitative priming with inactivated pertussis toxoid vaccine in the aerosol challenge model. Infect. Immun. 70:4600-4608.
9. Cassone, A., C. M. Ausiello, F. Urbani, R. Lande, M. Giuliano, A. La Sala, A. Piscitelli, S. Salmaso, and The Progetto Pertosse-CMI Working Group. 1997. Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. Arch. Pediatr. Adolesc. Med. 151:283-289.
10. Cassone, A., P. Mastrantonio, and C. M. Ausiello. 2000. Are only antibody levels involved in the protection against pertussis in acellular pertussis vaccine recipients? J. Infect. Dis. 182:1575-1577.
11. Cherry, J. D., J. Gornbein, U. Heininger, and K. Stehr. 1998. A search for serologic correlates of immunity to Bordetella pertussis cough illnesses. Vaccine 16:1901-1906.
12. de Greeff, S. C., J. F. Schellekens, F. R. Mooi, and H. E. de Melker. 2003. Pertussis in The Netherlands, 2001-2002. RIVM Report. RIVM, Bilthoven, The Netherlands.
13. de Greeff, S. C., J. F. Schellekens, F. R. Mooi, and H. E. de Melker. 2005. Effect of vaccination against pertussis on the incidence of pertussis in The Netherlands, 1996-2003. Ned. Tijdschr. Geneeskd. 149:937-943. (In Dutch.)
14. de Melker, H. E., F. G. Versteegh, M. A. Conyn-van Spaendonck, L. H. Elvers, G. A. Berbers, Z. A. van Der, and J. F. Schellekens. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38:800-806.
15. Health Council of The Netherlands. 2004. Vaccination against pertussis. Publication no. 2004/04E, p. 1-98. Health Council of The Netherlands, The Hague, The Netherlands. http://www.gr.nl/pdf.php?ID=964&p=1.
16. Higgins, S. C., A. G. Jarnicki, E. C. Lavelle, and K. H. Mills. 2006. TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells. J. Immunol. 177:7980-7989.
17. Higgins, S. C., E. C. Lavelle, C. McCann, B. Keogh, E. McNeela, P. Byrne, B. O'Gorman, A. Jarnicki, P. McGuirk, and K. H. Mills. 2003. Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J. Immunol. 171:3119-3127.
18. Kerfoot, S. M., E. M. Long, M. J. Hickey, G. Andonegui, B. M. Lapointe, R. C. Zanardo, C. Bonder, W. G. James, S. M. Robbins, and P. Kubes. 2004. TLR4 contributes to disease-inducing mechanisms resulting in central nervous system autoimmune disease. J. Immunol. 173:7070-7077.
19. Kimman, T. 2001. Genetics of infectious disease susceptibility. Kluwer Academic Publishers, Dordrecht, The Netherlands.
20. Kimman, T., R. J. Vandebriel, and B. Hoebee. Genetic variation in the response to vaccination. Community Genet., in press.
21. Kummeling, I., C. Thijs, J. Penders, B. E. Snijders, F. Stelma, J. Reimerink, M. Koopmans, P. C. Dagnelie, M. Huber, M. C. Jansen, R. de Bie, and P. A. van den Brandt. 2005. Etiology of atopy in infancy: the KOALA Birth Cohort Study. Pediatr. Allergy Immunol. 16:679-684.
22. Mahon, B. P., M. T. Brady, and K. H. Mills. 2000. Protection against Bordetella pertussis in mice in the absence of detectable circulating antibody: implications for long-term immunity in children. J. Infect. Dis. 181:2087-2091.
23. Mann, P. B., D. Wolfe, E. Latz, D. Golenbock, A. Preston, and E. T. Harvill. 2005. Comparative Toll-like receptor 4-mediated innate host defense to Bordetella infection. Infect. Immun. 73:8144-8152.
24. Mills, K. H., M. Ryan, E. Ryan, and B. P. Mahon. 1998. A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis. Infect. Immun. 66:594-602.
25. Poltorak, A., X. He, I. Smirnova, M. Y. Liu, C. Van Huffel, X. Du, D. Birdwell, E. Alejos, M. Silva, C. Galanos, M. Freudenberg, P. Ricciardi-Castagnoli, B. Layton, and B. Beutler. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085-2088.
26. Racke, M. K., W. Hu, and A. E. Lovett-Racke. 2005. PTX cruiser: driving autoimmunity via TLR4. Trends Immunol. 26:289-291.
27. RIVM. 2005. Reported cases of whooping cough in The Netherlands. CIE, RIVM, Bilthoven, The Netherlands. http://www.rivm.nl/isis/ggd/openbaar/ diag/aa/gr_aa_PERT.html. Accessed 23 February 2005.
28. RIVM. 2004. Vaccination coverage in The Netherlands. Zorgatlas, RIVM, Bilthoven, The Netherlands. http://www.rivm.nl/vtv/data/atlas/vaccinaties/ dktp_vacc_03.html. Accessed 23 February 2005.
29. Schroder, N. W., and R. R. Schumann. 2005. Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect. Dis. 5:156-164.
30. Storsaeter, J., H. O. Hallander, L. Gustafsson, and P. Olin. 1998. Levels of anti-pertussis antibodies related to protection after household exposure to Bordetella pertussis. Vaccine 16:1907-1916.
31. Taranger, J., B. Trollfors, T. Lagergard, V. Sundh, D. A. Bryla, R. Schneerson, and J. B. Robbins. 2000. Correlation between pertussis toxin IgG antibodies in postvaccination sera and subsequent protection against pertussis. J. Infect. Dis. 181:1010-1013.
32. Turvey, S. E., and T. R. Hawn. 2006. Towards subtlety: understanding the role of Toll-like receptor signaling in susceptibility to human infections. Clin. Immunol. 120:1-9.